Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:PC O-22:2/20:4)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST003751 AN006158 Comprehensive Lipidomic Analysis Identifies Critical Lipid and Metabolic Pathway Shifts in Alport Syndrome Blood Human Kidney disease Universidad CEU San Pablo LC-MS
ST003751 AN006158 Comprehensive Lipidomic Analysis Identifies Critical Lipid and Metabolic Pathway Shifts in Alport Syndrome Urine Human Kidney disease Universidad CEU San Pablo LC-MS
ST003751 AN006159 Comprehensive Lipidomic Analysis Identifies Critical Lipid and Metabolic Pathway Shifts in Alport Syndrome Blood Human Kidney disease Universidad CEU San Pablo LC-MS
ST003751 AN006159 Comprehensive Lipidomic Analysis Identifies Critical Lipid and Metabolic Pathway Shifts in Alport Syndrome Urine Human Kidney disease Universidad CEU San Pablo LC-MS
ST003694 AN006061 FOLFIRINOX effects on lipidomics in pancreatic cancer cells Pancreas Human Cancer Pennsylvania State University LC-MS
ST003672 AN006029 Advanced Lipidomics Using UHPLC-ESI-QTOF-MS/MS Reveals Novel Lipids in Hibernating Syrian Hamsters Brain Golden hamster Universidad CEU San Pablo LC-MS
ST003637 AN005973 lomitapide effects on lipidomics Pancreas Human Cancer Pennsylvania State University LC-MS
ST003157 AN005179 Diet modulates the protective effects of dimethyl fumarate mediated by the immunometabolic neutrophil receptor HCA2 - Lipidomics Blood Mouse Multiple sclerosis University of Luebeck LC-MS
  logo